# Johnson & Johnson Reports Positive 30-Day Shockwave Javelin Results

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/46018
Published: 2026-11-02T00:06:37.000Z
Updated: 2026-11-02T00:06:37.000Z
Section: Business

> The FORWARD CAD trial evaluated an experimental catheter for severely narrowed coronary arteries that can be difficult to reach with conventional devices.

Johnson & Johnson reported positive results through 30 days from its FORWARD CAD clinical trial on Nov. 1. The study evaluated the company’s experimental Shockwave Javelin catheter.

The catheter is being developed for severely narrowed coronary arteries that conventional devices can have difficulty reaching.